4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-6-(TRIFLUOROMETHYL)-1H-INDOLE, 95.0%, 500mg

DANIRIXIN, 25mg

Methyl 3-amino-5-methoxy-pyridine-2-carboxylate, 98%, 250mg

Viales de reacción ROTILABO® 0,5 ml, 1000 Unidad(es)

(S)-Octan-2-ol, 95.0%, 1g

3-(4-Chlorophenoxymethyl)benzoic acid, 95.0%, 100mg

(S)-3,3'-Dichloro-[1,1'-binaphthalene]-2,2'-diol, 98%, 1g

Lithium sulfate monohydrate, 99.9%, 25g

4-(2-Chloro-pyridine-3-carbonyl)-piperazine-1,3-dicarboxylic acid 1-tert-butyl ester, 95.0%, 500mg

2-Azetidinecarboxylic acid, 3,3-dimethyl-, (2S)-, 95.0%, 1g

Hexaclororenato(IV) de potasio (base metálica) 99,95% 1 g

4-METHYL-1-(PIPERIDIN-1-YL)PENTAN-1-ONE, 95.0%, 1g

2-Chloro-3,4-difluorobenzaldehyde, 95.0%, 100mg